Smoking prevalence and attributable disease burden in 195 countries and territories, 1990-2015: a systematic analysis from the Global Burden of Disease Study 2015
- PMID: 28390697
- PMCID: PMC5439023
- DOI: 10.1016/S0140-6736(17)30819-X
Smoking prevalence and attributable disease burden in 195 countries and territories, 1990-2015: a systematic analysis from the Global Burden of Disease Study 2015
Erratum in
-
Department of Error.Lancet. 2017 Oct 7;390(10103):1644. doi: 10.1016/S0140-6736(17)32559-X. Epub 2017 Oct 5. Lancet. 2017. PMID: 29131796 Free PMC article. No abstract available.
Abstract
Background: The scale-up of tobacco control, especially after the adoption of the Framework Convention for Tobacco Control, is a major public health success story. Nonetheless, smoking remains a leading risk for early death and disability worldwide, and therefore continues to require sustained political commitment. The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) offers a robust platform through which global, regional, and national progress toward achieving smoking-related targets can be assessed.
Methods: We synthesised 2818 data sources with spatiotemporal Gaussian process regression and produced estimates of daily smoking prevalence by sex, age group, and year for 195 countries and territories from 1990 to 2015. We analysed 38 risk-outcome pairs to generate estimates of smoking-attributable mortality and disease burden, as measured by disability-adjusted life-years (DALYs). We then performed a cohort analysis of smoking prevalence by birth-year cohort to better understand temporal age patterns in smoking. We also did a decomposition analysis, in which we parsed out changes in all-cause smoking-attributable DALYs due to changes in population growth, population ageing, smoking prevalence, and risk-deleted DALY rates. Finally, we explored results by level of development using the Socio-demographic Index (SDI).
Findings: Worldwide, the age-standardised prevalence of daily smoking was 25·0% (95% uncertainty interval [UI] 24·2-25·7) for men and 5·4% (5·1-5·7) for women, representing 28·4% (25·8-31·1) and 34·4% (29·4-38·6) reductions, respectively, since 1990. A greater percentage of countries and territories achieved significant annualised rates of decline in smoking prevalence from 1990 to 2005 than in between 2005 and 2015; however, only four countries had significant annualised increases in smoking prevalence between 2005 and 2015 (Congo [Brazzaville] and Azerbaijan for men and Kuwait and Timor-Leste for women). In 2015, 11·5% of global deaths (6·4 million [95% UI 5·7-7·0 million]) were attributable to smoking worldwide, of which 52·2% took place in four countries (China, India, the USA, and Russia). Smoking was ranked among the five leading risk factors by DALYs in 109 countries and territories in 2015, rising from 88 geographies in 1990. In terms of birth cohorts, male smoking prevalence followed similar age patterns across levels of SDI, whereas much more heterogeneity was found in age patterns for female smokers by level of development. While smoking prevalence and risk-deleted DALY rates mostly decreased by sex and SDI quintile, population growth, population ageing, or a combination of both, drove rises in overall smoking-attributable DALYs in low-SDI to middle-SDI geographies between 2005 and 2015.
Interpretation: The pace of progress in reducing smoking prevalence has been heterogeneous across geographies, development status, and sex, and as highlighted by more recent trends, maintaining past rates of decline should not be taken for granted, especially in women and in low-SDI to middle-SDI countries. Beyond the effect of the tobacco industry and societal mores, a crucial challenge facing tobacco control initiatives is that demographic forces are poised to heighten smoking's global toll, unless progress in preventing initiation and promoting cessation can be substantially accelerated. Greater success in tobacco control is possible but requires effective, comprehensive, and adequately implemented and enforced policies, which might in turn require global and national levels of political commitment beyond what has been achieved during the past 25 years.
Funding: Bill & Melinda Gates Foundation and Bloomberg Philanthropies.
Copyright © 2017 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved.
Figures
Similar articles
-
Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.Lancet. 2018 Nov 10;392(10159):1923-1994. doi: 10.1016/S0140-6736(18)32225-6. Epub 2018 Nov 8. Lancet. 2018. PMID: 30496105 Free PMC article.
-
Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970-2016: a systematic analysis for the Global Burden of Disease Study 2016.Lancet. 2017 Sep 16;390(10100):1084-1150. doi: 10.1016/S0140-6736(17)31833-0. Lancet. 2017. PMID: 28919115 Free PMC article.
-
Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.Lancet Respir Med. 2017 Sep;5(9):691-706. doi: 10.1016/S2213-2600(17)30293-X. Epub 2017 Aug 16. Lancet Respir Med. 2017. PMID: 28822787 Free PMC article.
-
Alcohol use and burden for 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.Lancet. 2018 Sep 22;392(10152):1015-1035. doi: 10.1016/S0140-6736(18)31310-2. Epub 2018 Aug 23. Lancet. 2018. PMID: 30146330 Free PMC article. Review.
-
Global burden and risk factors of musculoskeletal disorders among adolescents and young adults in 204 countries and territories, 1990-2019.Autoimmun Rev. 2023 Aug;22(8):103361. doi: 10.1016/j.autrev.2023.103361. Epub 2023 May 23. Autoimmun Rev. 2023. PMID: 37230312 Review.
Cited by
-
Prevalence and predictors of coronary heart disease among individuals with and without obesity in North Dakota.PLoS One. 2024 Nov 8;19(11):e0313283. doi: 10.1371/journal.pone.0313283. eCollection 2024. PLoS One. 2024. PMID: 39514528 Free PMC article.
-
Factors Related to Tobacco Cessation Attempts Among Turkish Adolescents: A Structural Equation Model Analysis.Thorac Res Pract. 2024 Nov 1;25(3):197-202. doi: 10.5152/ThoracResPract.2024.23129. Thorac Res Pract. 2024. PMID: 39511795 Free PMC article.
-
Social norms and social opportunities: a qualitative study of influences on tobacco use among urban adolescent girls in Ghana.BMC Public Health. 2024 Oct 28;24(1):2978. doi: 10.1186/s12889-024-20413-z. BMC Public Health. 2024. PMID: 39468503 Free PMC article.
-
Substance use and lifestyle risk factors for somatic disorders among psychiatric patients in Greenland.Int J Circumpolar Health. 2024 Dec;83(1):2421049. doi: 10.1080/22423982.2024.2421049. Epub 2024 Oct 27. Int J Circumpolar Health. 2024. PMID: 39462457 Free PMC article.
-
Global burden of ischemic stroke attributable to high body mass index in 204 countries and territories, 1990-2021.BMC Cardiovasc Disord. 2024 Oct 22;24(1):584. doi: 10.1186/s12872-024-04259-2. BMC Cardiovasc Disord. 2024. PMID: 39438799 Free PMC article.
References
-
- Forouzanfar MH, Afshin A, Alexander LT. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388:1659–1724. - PMC - PubMed
-
- Jha P, Peto R. Global effects of smoking, of quitting, and of taxing tobacco. N Engl J Med. 2014;370:60–68. - PubMed
-
- Jha P. Deaths and taxes: stronger global tobacco control by 2025. Lancet. 2015;385:918–920. - PubMed
-
- Lancet T. What will it take to create a tobacco-free world? Lancet. 2015;385:915. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous